SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$308.96

Market cap

$118.44B

P/E Ratio

35.35

Dividend/share

$3.44

EPS

$8.74

Enterprise value

$130.29B

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 23
Relative Valuation: Rel. Valuation: 39
Relative Profitability: Rel. Profitability: 83

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; ...

Highlights
SYK's quick ratio is up by 29% YoY
SYK's P/E is 22% below its last 4 quarters average of 44.7 and 19% below its 5-year quarterly average of 42.8
Sector: Healthcare
Industry: Medical Devices
Website: https://www.stryker.com/
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK

SYK stock price

How has the Stryker stock price performed over time
Intraday
1.4%
1 week
-0.52%
1 month
-2.38%
1 year
-18.51%
YTD
-12.09%
QTD
-5.97%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$25.27B
Gross profit
$16.13B
Operating income
$4.99B
Net income
$3.34B
Gross margin
63.8%
Net margin
13.2%
The operating income has grown by 40% year-on-year and by 2% since the previous quarter
Stryker's operating margin has increased by 29% YoY
SYK's net income is up by 17% year-on-year and by 2.8% since the previous quarter
Stryker's gross profit has increased by 9% YoY

Price vs fundamentals

How does SYK's price correlate with its fundamentals

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
SYK P/E details
P/E
35.35
P/B
5.15
P/S
4.68
EV/EBIT
24.33
EV/EBITDA
22.34
EV/Sales
5.16
SYK's P/E is 22% below its last 4 quarters average of 44.7 and 19% below its 5-year quarterly average of 42.8
Stryker's EPS has increased by 17% YoY and by 2.9% from the previous quarter
SYK's P/B is 20% below its 5-year quarterly average of 6.3 and 20% below its last 4 quarters average of 6.3
SYK's equity is up by 10% year-on-year and by 2.5% since the previous quarter
The stock's price to sales (P/S) is 19% less than its 5-year quarterly average of 5.7 and 18% less than its last 4 quarters average of 5.6
The company's revenue rose by 9% YoY

Efficiency

How efficient is Stryker business performance
Stryker's ROS has increased by 27% YoY and by 3.9% from the previous quarter
Stryker's ROIC has increased by 27% YoY and by 4.8% from the previous quarter
The ROE rose by 8% YoY
The ROA has grown by 6% YoY and by 2.9% from the previous quarter

Dividends

What is SYK's dividend history
Dividend details
DPS
$3.44
Dividend yield
1.11%
Payout ratio
39.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Stryker financials performed over time
The total assets is 99% greater than the total liabilities
SYK's quick ratio is up by 29% YoY
The current ratio has grown by 29% year-on-year and by 12% since the previous quarter
SYK's debt is 36% less than its equity
The debt to equity has contracted by 20% YoY and by 10% from the previous quarter
SYK's debt is down by 12% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.